SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition

Kim, Eunhee, Ilagan, Janine O., Liang, Yang, Daubner, Gerrit M., Lee, Stanley C.-W., Ramakrishnan, Aravind, Li, Yue, Chung, Young Rock +17 more·2015·Cancer Cell

DOI 10.1016/j.ccell.2015.04.006

Cited by (582)

Items 301–400 of 582

Phosphorylation mediated regulation of RNA splicing in plants
Maria Camila Rodriguez Gallo, R. Glen Uhrig · 2023 · Frontiers in Plant Science
Insights from structures of cancer-relevant pre-mRNA splicing factors
Clara L. Kielkopf · 2017 · Current Opinion in Genetics & Development
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
Yotaro Ochi, Seishi Ogawa · 2021 · Cancers
Epigenetic dysregulation in myeloid malignancies.
Hsuan-Ting Huang, M. Figueroa · 2021 · Blood
Emerging biological therapies for the treatment of myelodysplastic syndromes
Amer Methqal Zeidan, Maximilian F. Stahl, Rami S. Komrokji · 2016 · Expert Opinion on Emerging Drugs
Biological relevance of alternative splicing in hematologic malignancies
Monika Szelest, Krzysztof Giannopoulos · 2024 · Molecular Medicine
Genetic and environmental risks for clonal hematopoiesis and cancer
Stephanie Franco, Lucy A. Godley · 2024 · The Journal of Experimental Medicine
Modeling human RNA spliceosome mutations in the mouse: not all mice were created equal
Jane Jialu Xu, Monique F. M. A. Smeets, Shuh Ying Tan, Meaghan Wall, Louise E. Purton, Carl R. Walkley · 2018 · Experimental Hematology
Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia
Ryan Michael Carr, Mrinal M. Patnaik · 2019 · Current Opinion in Hematology
Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
Nicola Daniele Andina, Nicolas Bonadies, Ramanjaneyulu Allam · 2022 · Frontiers in Cell and Developmental Biology
Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
Youshan Zhao, Juan Guo, Sida Zhao, Roujia Wang, Lei Shi, Ying Fang, Zheng Zhang, Luxi Song, Dong Wu, Chunkang Chang · 2022 · Cancers
RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS
Yi-Jou Huang, Jiayu Chen, Ming Yan, Amanda G Davis, Sayuri Miyauchi, Liang Chen, Yajing Hao, Sigrid Katz, Rafael L. Bejar, Omar Ibrahim Abdel-Wahab et al. · 2022 · Blood Advances
A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations
Xiao Li, Feng Xu, Lingyun Wu, Youshan Zhao, Juan Guo, Qi He, Zheng Zhang, Chunkang Chang, Dong Wu · 2020 · Scientific Reports
Genetic basis of myelodysplastic syndromes
Seishi Ogawa · 2020 · Proceedings of the Japan Academy Series B
Targeting Aberrant Splicing in Myelodysplastic Syndromes
Andrew Mark Brunner, David P. Steensma · 2019 · Hematology/Oncology Clinics of North America
Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
Vasundhara Sharma, Kenneth L. Wright, Pearlie K. Epling‐Burnette, Gary W. Reuther · 2020 · Frontiers in Immunology
Impact of splicing factor mutations on clinical features in patients with myelodysplastic syndromes
Naoki Shingai, Yuka Harada, Hiroko Iizuka, Yosuke Ogata, Noriko Doki, Kazuteru Ohashi, Masao Hagihara, Norio Komatsu, Hironori Harada · 2018 · International Journal of Hematology
Sequence and Evolutionary Features for the Alternatively Spliced Exons of Eukaryotic Genes
Shiyi Chen, Cao Li, Xianbo Jia, Songjia Lai · 2019 · International Journal of Molecular Sciences
A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5′UTRGATA1sSplice Mutation
Jacob P. Zucker, Constance J. Temm, Magdalena Czader, Grzegorz Nalepa · 2015 · Pediatric Blood & Cancer
Secondary-Type Mutations in Acute Myeloid Leukemia: Updates from ELN 2022
Ian Michael Bouligny, Keri Renee Maher, Steven Grant · 2023 · Cancers
Small molecule inhibition of RNA binding proteins in haematologic cancer
Amit Kumar Jaiswal, Michelle L. Thaxton, Georgia Scherer, Jacob P. Sorrentino, Neil K. Garg, Dinesh S. Rao · 2024 · RNA Biology
RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma
Jiang Chang, Yaodong Zhang, Tao Zhou, Qian Qiao, Jijun Shan, Yananlan Chen, Wangjie Jiang, Yirui Wang, Shuochen Liu, Yuming Wang et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers
Tingting Zhao, Zhe Zhang, Zhuo Chen, Guozheng Xu, Yongxi Wang, Fang Wang · 2025 · Frontiers in Oncology
Insights on mechanisms of clonal evolution in chronic neutrophilic leukemia on ruxolitinib therapy
Ryan C. Stoner, Richard D. Press, Julia E. Maxson, Jeffrey W Tyner, Kim-Hien T. Dao · 2019 · Leukemia
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variants
Gorka Ruiz de Garibay Ponce, Ignacio Fernandez‐Garcia, Sylvie Mazoyer, Flávia Leme de Calais, Pietro Ameri, Sangeetha Vijayakumar, Haydeliz Martinez‐Ruiz, Francesca Damiola, Laure Barjhoux, Mads Thomassen et al. · 2021 · Human Mutation
Leukemic Transformation of Myeloproliferative Neoplasms: Therapeutic and Genomic Considerations
Bing Li, John O Mascarenhas, Raajit K. Rampal · 2018 · Current Hematologic Malignancy Reports
RNA Regulators in Leukemia and Lymphoma
Camila Prieto, Michael G. Kharas · 2019 · Cold Spring Harbor Perspectives in Medicine
Targeting low-risk myelodysplastic syndrome with novel therapeutic strategies
Gaurang Trivedi, Daichi Inoue, Lingbo Zhang · 2021 · Trends in Molecular Medicine
Post-transcriptional regulation of erythropoiesis
Yanan Li, Haihang Zhang, Bin Hu, Pan Wang, Wei Wang, Jing Liu · 2023 · Blood Science
SRSF2 mutation cooperates with ASXL1 truncated alteration to accelerate leukemogenesis
Pinpin Sui, Guo Ge, Chen Shi, Jiaojiao Bai, Ivan P. Rubalcava, Hui Yang, Ying Guo, Peng Zhang, Ying Li, Edward Antonio Medina et al. · 2023 · Leukemia
Emerging drugs for the treatment of chronic myelomonocytic leukemia
Jorge Ramos Perez, Guillermo Montalban Bravo · 2020 · Expert Opinion on Emerging Drugs
Alternative mRNA Splicing and Promising Therapies in Cancer
James D. Fackenthal · 2023 · Biomolecules
Activation of Cryptic 3′ Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping
Heegyum Moon, Ha Na Jang, Yongchao Liu, Namjeong Choi, Jagyeong Oh, Jiyeon Ha, Xuexiu Zheng, Haihong Shen · 2019 · Cells
Regulating Divergent Transcriptomes through mRNA Splicing and Its Modulation Using Various Small Compounds
Ken‐ichi Fujita, Takaki Ishizuka, Mizuki Mitsukawa, Masashi Kurata, Seiji Masuda · 2020 · International Journal of Molecular Sciences
Clinical and Mechanistic Implications of R-Loops in Human Leukemias
Seo Yun Lee, Kyle M. Miller, Jae‐Jin Kim · 2023 · International Journal of Molecular Sciences
The evolution of preclinical models for myelodysplastic neoplasms
Alain Antoine Mina, Steven Zivko Pavletic, Peter D. Aplan · 2024 · Leukemia
Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics
Nicole Santoro, P. Salutari, M. Di Ianni, Andrea Marra · 2024 · International Journal of Molecular Sciences
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
In Young Choi, Jonathan P. Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Panagiotis Tsakiroglou, Riley E. Bergman, Céline Philippe, James L. Manley, Kevin Rouault‐Pierre et al. · 2024 · Blood Advances
SRSF2 safeguards efficient transcription of DNA damage and repair genes
Rebecca E. Wagner, Leonie Arnetzl, Thiago Britto‐Borges, Anke Heit-Mondrzyk, Ali Bakr, Etienne Sollier, Nikoletta A. Gkatza, Jasper Panten, Sylvain Delaunay, Daniela Sohn et al. · 2024 · Cell Reports
What are the most promising new agents in acute myeloid leukemia?
David Andrew Sallman, Jeffrey E. Lancet · 2017 · Current Opinion in Hematology
SOHO State of the Art Update and Next Questions: Biology and Treatment of Myelodysplastic Syndromes
David Andrew Sallman, Tiffany N. Tanaka, Alan F. List, Rafael L. Bejar · 2017 · Clinical Lymphoma Myeloma & Leukemia
Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression
Mark Sellin, Ryan Michael Mack, Matthew C. Rhodes, Lei Zhang, Stephanie A Berg, Kanak Joshi, Shanhui Liu, Wei Wei, Peter Breslin, Peter Larsen et al. · 2022 · British Journal of Cancer
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromes
Ali Sakhdari, Caleb A. Class, Guillermo Montalban Bravo, Koji Sasaki, Carlos Bueso-Ramos, Keyur Pravinchandra Patel, Mark J. Routbort, Sanam Loghavi, Chi Young Ok, Andres Ernesto Quesada et al. · 2022 · Modern Pathology
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia
Peter J.P. Croucher, Maya Ridinger, Pamela Sue Becker, Tara L. Lin, Sandra Silberman, Eunice S. Wang, Amer Methqal Zeidan · 2023 · Annals of Hematology
Therapeutic targeting of RNA splicing in myelodysplasia
Young Joon Kim, Omar Ibrahim Abdel-Wahab · 2017 · Seminars in Hematology
Transcriptomic rationale for synthetic lethality‐targeting ERCC 1 and CDKN 1A in chronic myelomonocytic leukaemia
Ana María Hurtado, Ginés Luengo‐Gil, Tzu Hua Chen‐Liang, Fabio M. R. Amaral, Kiran Batta, Laura Palomo, Eva Lumbreras, Bartlomiej P. Przychodzen, Eva Caparrós-Pérez, María Luz Amigo et al. · 2018 · British Journal of Haematology
Molecular landscape in acute myeloid leukemia: where do we stand in 2016
Karam Al-Issa, Nazha Aziz · 2016 · Cancer Biology and Medicine
Splicing machinery genomics events in acute myeloid leukaemia (AML): in search for therapeutic targets, diagnostic and prognostic biomarkers.
Zodwa Dlamini, Bonginkosi Shoba, Rodney Hull · 2020 · PubMed Central
Stem Cells in the Myelodysplastic Syndromes
Di Zhan, Christopher Y. Park · 2021 · Frontiers in Aging
Disease modifying agents of myeloproliferative neoplasms: a review
Sung‐Eun Lee · 2021 · Blood Research
RNA Splicing as a Therapeutic Target in Cancer
Alexander M. Lewis, Kenyon Weis, Omar Ibrahim Abdel-Wahab · 2025 · The Annual Review of Pharmacology and Toxicology
Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations
Maki Sakuma, Amy K. Wang, Samuel J. Magaziner, Sachiko P. Keane, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, David B. Beck, Wencke Walter · 2025 · Leukemia
Therapeutic approaches targeting splicing factor mutations in myelodysplastic syndromes and acute myeloid leukemia
John Figg, Juan Martin Barajas, Esther A. Obeng · 2021 · Current Opinion in Hematology
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm
Yue Yang, Salar Abbas, Mohammad Abu Sayem, Avik Dutta, Golam Mohi · 2023 · Blood Cancer Journal
Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies
Marcus Bauer, Chiara-Maria Schöbel, Claudia Wickenhauser, Barbara Seliger, Simon Jasinski‐Bergner · 2024 · Frontiers in Immunology
Aberrant pre-mRNA processing in cancer
Jeetayu Biswas, Leora S. Boussi, Eytan M. Stein, Omar Ibrahim Abdel-Wahab · 2024 · The Journal of Experimental Medicine
Splicing regulatory dynamics for precision analysis and treatment of heterogeneous leukemias
Meenakshi Venkatasubramanian, Leya Y Schwartz, Nandini Ramachandra, Joshua R. Bennett, Krithika R. Subramanian, Xiaoting Chen, Shanisha Gordon-Mitchell, Ariel A. Fromowitz, Kith Pradhan, David Shechter et al. · 2025 · Science Translational Medicine
A common structural mechanism for RNA recognition by the SF3B complex in mRNA splicing and export
Yuzhu Zhang, Changping Yin, Yimin Wang, Kunming Yan, Bo Zhao, Xin Hu, Youzhong Wan, Hong Cheng, Jing Huang · 2025 · Nucleic Acids Research
Spliceosomal factor mutations and mis-splicing in MDS
Courtney E. Hershberger, Noah J. Daniels, Richard A. Padgett · 2020 · Best Practice & Research Clinical Haematology
RNA splicing as a therapeutic target in myelodysplastic syndromes
Chun-Chih Tseng, Esther A. Obeng · 2024 · Seminars in Hematology
Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?
Eric Padron · 2015 · Hematology
Translocation of a Cell Surface Spliceosomal Complex Induces Alternative Splicing Events and Lymphoma Cell Necrosis
Sonal S. Tonapi, Vaishali Pannu, Janet E. Duncan, Matthew A. Rosenow, Anthony Helmstetter, Daniel Magee, Qing Zhang, Teresa T. Tinder, Melissa N. Richards, David D. Halbert et al. · 2019 · Cell chemical biology
A CRISPR RNA-binding protein screen reveals regulators of RUNX1 isoform generation
Amanda G Davis, Jaclyn M. Einstein, Dinghai Zheng, Nathan D. Jayne, Xiang‐Dong Fu, Bin Tian, Gene Wei-Ming Yeo, Dong‐Er Zhang · 2021 · Blood Advances
Clonal haematopoiesis of emerging significance
Danielle E. Hammond, Sanam Loghavi · 2021 · Pathology
The spliceosome factor sart3 regulates hematopoietic stem/progenitor cell development in zebrafish through the p53 pathway
Yan Zhao, Mei Wu, Jing Li, Ping Meng, Jiakui Chen, Zhibin Huang, Jin Xu, Zilong Wen, Wenqing Zhang, Yiyue Zhang · 2021 · Cell Death and Disease
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
Diletta Fontana, Carlo B Gambacorti-Passerini, Rocco Piazza · 2021 · Frontiers in Oncology
Advances in understanding the molecular basis of clonal hematopoiesis
David A. Alagpulinsa, Mabel P. Toribio, Iad Alhallak, Robert J. Shmookler Reis · 2022 · Trends in Molecular Medicine
Role of computational and structural biology in the development of small-molecule modulators of the spliceosome
Riccardo Rozza, Pavel Janoš, Angelo Spinello, Alessandra Magistrato · 2022 · Expert Opinion on Drug Discovery
Novel Molecular Insights into Leukemic Evolution of Myeloproliferative Neoplasms: A Single Cell Perspective
Sebastiano Rontauroli, Chiara Carretta, Sandra Parenti, Matteo Bertesi, Rossella Manfredini · 2022 · International Journal of Molecular Sciences
Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
Lindsey M. Skrdlant, Jeremy M. Stark, Ren-Jang Lin · 2016 · BMC Molecular Biology
Identification and Functional Characterization of a New Splicing Variant of EZH2 in the Central Nervous System
Danyang Li, Huili Wang, Xiyao Huang, Xiaozhen Gu, Weizhen Xue, Yi Xu · 2018 · International Journal of Biological Sciences
Genetic complexity of chronic myelomonocytic leukemia
Ami B. Patel, Michael W. Deininger · 2020 · Leukemia & lymphoma/Leukemia and lymphoma
Probing Isoform Switching Events in Various Cancer Types: Lessons From Pan-Cancer Studies
Tülay Karakulak, Holger Moch, Christian von Mering, Abdullah Kahraman · 2021 · Frontiers in Molecular Biosciences
Identification of a specific immunophenotype associated with a consistent pattern of genetic mutations including SRFS2 and gene expression profile in MDS
Elisabeth H. Weiss, Wencke Walter, Manja Meggendorfer, Constance Regina Baer, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern · 2022 · Cytometry Part B Clinical Cytometry
Alternatively spliced CSF3R isoforms in SRSF2 P95H mutated myeloid neoplasms
Borwyn A. Wang, Hrishikesh Mehta, Srinivasa R. Penumutchu, Blanton S. Tolbert, Chonghui Cheng, Marek Kimmel, Torsten Haferlach, Jaroslaw Pawel Maciejewski, Seth Joel Corey · 2022 · Leukemia
RETRACTED: Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies
Mariam Markouli, Dimitrios Strepkos, Christina Piperi · 2022 · International Journal of Molecular Sciences · Retracted
A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers
David Wang, Mathieu Quesnel-Vallières, San Jewell, Moein Elzubeir, Kristen W. Lynch, Andrei Thomas‐Tikhonenko, Yoseph Barash · 2023 · Nature Communications
The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression
Youmna Sami Kfoury, Fei Ji, Esha Jain, Michael C. Mazzola, Giulia Schiroli, Ani Papazian, François Mercier, David B. Sykes, Anna Kiem, Mark A. Randolph et al. · 2023 · Blood Advances
Noncoding rules of survival: epigenetic regulation of normal and malignant hematopoiesis
LaShanale M. Wallace, Esther A. Obeng · 2023 · Frontiers in Molecular Biosciences
Hyperactivation of NF-κB signaling in splicing factor mutant myelodysplastic syndromes and therapeutic approaches
Andrea Pellagatti, Jacqueline Boultwood · 2024 · Advances in Biological Regulation
Blood Relatives: Splicing Mechanisms underlying Erythropoiesis in Health and Disease
Kirsten A. Reimer, Karla M. Neugebauer · 2018 · F1000Research
SplicingFactory—splicing diversity analysis for transcriptome data
Benedek Dankó, Péter Szikora, Tamás Pór, Alexa Szeifert, Endre Sebestyén · 2021 · Bioinformatics
Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process
Nathalie Douet‐Guilbert, Benoît Soubise, Delphine G. Bernard, Marie‐Bérengère Troadec · 2022 · Diagnostics
DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes
Nanfang Huang, Song Yang, Wenhui Shi, Juan Guo, Zheng Zhang, Qi He, Lingyun Wu, Xiao Li, Feng Xu · 2023 · iScience
Charting the “Splice” Routes to MDS
Esther A. Obeng, Benjamin L. Ebert · 2015 · Cancer Cell
Refractory macrocytic anemias in patients with clonal hematopoietic disorders and isolated mutations of the spliceosome gene ZRSR2
Roger A. Fleischman, Shannon Somer Stockton, Christopher Ramin Cogle · 2017 · Leukemia Research
Role of alternative splicing in hematopoietic stem cells during development
Yimeng Gao, Radovan Vasic, Stephanie Halene · 2018 · Stem Cell Investigation
Alternative Splicing in Myeloid Malignancies
Carmelo Gurnari, Simona Pagliuca, Valeria Visconte · 2021 · Biomedicines
Cell-autonomous dysregulation of interferon signaling drives clonal expansion of SRSF2-mutant MDS stem/progenitor cells
Kouhei Takashima, Malgorzata Olszewska, Vrinda Jethalia, Maria Sirenko, Lewis R. Silverman, Lewis E. Tomalin, Saul Carcamo, Dan Hasson, Eirini P. Papapetrou · 2025 · Blood
Nonsense-mediated mRNA decay: a key regulatory system engaged in cancer
Hongyu Pan, Xinyu Wu, Bingshuang Hu, Huihua Xiong, Yao Luo, Jiankang Zhou · 2025 · Cell Communication and Signaling
Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment
Sisi Chen, Sergio Barajas, Sasidhar Vemula, Yuxia Yang, Edward R. Simpson, Hongyu Gao, Rudong Li, Farzaneh Behzadnia, Sarah C. Nabinger, David A. Schmitz et al. · 2025 · Journal of Clinical Investigation
Splicing regulation in hematopoiesis
Sisi Chen, Omar Ibrahim Abdel-Wahab · 2021 · Current Opinion in Hematology
Assessing the role of intrinsic disorder in RNA-binding protein function: hnRNP K as a case study
Prerna Malaney, Oscar Benitez, Xiaorui Zhang, Sean M. Post · 2022 · Methods
Splicing factor deficits render hematopoietic stem and progenitor cells sensitive to STAT3 inhibition
Kathryn S. Potts, Rosannah C. Cameron, Amina Metidji, Noura Ghazale, LaShanale M. Wallace, Ana I. Leal-Cervantes, Reid Palumbo, Juan Martin Barajas, Varun Gupta, Srinivas Aluri et al. · 2022 · Cell Reports
Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia
Joshua Tatarian, Natalie Tupper, Peng Li, Julie Ellen Feusier, Maryam Abdo, Stephen D. Hyter, Patrick R. Gonzales, Da Zhang, Janet M. Woodroof, Sarah M. Kelting et al. · 2023 · American Journal of Clinical Pathology
The genomic landscape of myeloid neoplasms with myelodysplasia and its clinical implications
Luca Malcovati, Ilaria Ambaglio, Chiara Elena · 2015 · Current Opinion in Oncology
RNA binding protein‐directed control of leukemic stem cell evolution and function
Pratik Joshi, Ava Keyvani Chahi, Lina Liu, Steven Moreira, Ana Vujovic, Kristin J. Hope · 2024 · HemaSphere
RNA splicing factor Rbm25 underlies heterogeneous preleukemic clonal expansion in mice
Charles S. Bramlett, Jiya Eerdeng, Jiang Du, Yeachan Lee, Ivon Garcia, Mary Vergel-Rodriguez, Patrick Condie, Anna Nogalska, Rong Lu · 2023 · Blood
Post-transcriptional Regulation of Gene Expression via Unproductive Splicing
Lev G. Zavileyskiy, Dmitri Davidovich Pervouchine · 2024 · Acta Naturae
Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes
Naoyuki Kataoka, Eri Matsumoto, So Masaki · 2021 · International Journal of Molecular Sciences